Skip navigation

Vaccine Production:

Potential Engineering Approaches to a Pandemic

Conference Speakers

Michael J. Akers, PhD
Senior Director, Pharmaceutical Research and Development,
Baxter BioPharma Solutions
Biographical Sketch

Roy Anderson, FRS, FMEDSCI
Professor of Epidemiology, Imperial College, London, UK
Biographical Sketch

Norman W. Baylor, PhD
Director, Office of Vaccines Review and Research, CBER
Food and Drug Administration
Biographical Sketch

Michael Callahan MD, DTM&H
Division of Infectious Diseases, Massachusetts General Hospital
Program Manager, Avian Influenza Surveillance, U.S. Dept of State, Office of Cooperative Threat Reduction and Defense Science Office/DARPA
Biographical Sketch

S. Eric Cregger
Associate Technical Fellow, The Boeing Company
Biographical Sketch

David Estell, PhD
Vice President of Technology, Genencor International
Biographical Sketch

Bruce Gellin, MD, MPH
Director National Vaccine Program Office
Department of Health and Human Services

Phillip R. Green
Senior Scientist, The Procter & Gamble Company
Biographical Sketch

Shawn Knopp, PhD
Project Manager, Baxter BioPharma Solutions
Biographical Sketch

Ingrid Maes
Consultant, Innovative Technologies
Siemens AG, Competence Center Pharmaceutics
Biographical Sketch

Etienne Malhaise
Manager of TS Process Biotech, GSK Biologicals

James T. Matthews, PhD
Senior Director, Public Policy, Science and Health Policy
sanofi pasteur, US
Biographical Sketch

Kim Nelson, PhD
Senior Associate and Director, Biopharm Services
CRB Consulting Engineers
Biographical Sketch

Rino Rappuoli, PhD
Chief Scientist, Chiron Vaccines Research
Biographical Sketch

Lada Rasochova, PhD
R&D Group Leader, Dowpharma - Vaccines
Biographical Sketch

Patrick Scannon MD, PhD
Chief Scientific and Medical Officer, Xoma, Ltd.
Biographical Sketch

Alan R. Shaw, PhD
President and CEO, VaxInnate
Biographical Sketch

Charles Squires
Senior Director, Molecular Biology, Biochemistry & Genomics
Dowpharma

Dr. Klaus Stöhr, PhD
Head, WHO Influenza Team
Biographical Sketch

William L. Warren, PhD
CEO, VaxDesign Corporation
Biographical Sketch

Vaccine Production: Potential Engineering Approaches to a Pandemic
April 10-11, 2006

Conference Information: email Arthur Heuer at arthur.heuer@case.edu

Copyright © 2006 Northern Ohio Steering Group

If you can read this message you probably are using a browser that is out dated.
Your internet browsing experience will improve by simply upgrading your browser
to the current version.